Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

3.97
Delayed Data
As of 12:59pm ET
 -0.0144 / -0.36%
Today’s Change
1.65
Today|||52-Week Range
15.60
+127.91%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
AssetsCash155.4M183.0M243.4M239.5M
 
 
 
 
 
Short Term Investment Cash1.2M-87.5M10.2M-3.7M
 
 
 
 
 
Cash & Short Term Investments214.0M242.1M264.4M241.0M
 
 
 
 
 
 
ReceivablesReceivables6.8M2.8M2.9M2.1M
 
 
 
 
 
 
InventoriesInventories10.8M15.0M11.5M24.0M
 
 
 
 
 
 
Current AssetsOther Current Assets2.3M2.6M4.0M6.1M
 
 
 
 
 
Current Assets233.9M262.4M282.7M273.2M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross3.5M3.7M3.8M3.8M
 
 
 
 
 
Depreciation-2.2M-2.3M-2.4M-2.5M
 
 
 
 
 
Intangible Assets--0.00--78.0M
 
 
Other Assets1.3M60.9M61.2M81.2M
 
 
 
 
 
Total Assets236.6M375.0M345.4M355.8M
 
 
 
 
 
 
LiabilitiesAccounts Payable6.5M4.6M4.1M12.0M
 
 
 
 
 
Accrued Expenses10.4M14.1M17.4M18.8M
 
 
 
 
 
Other Current Liabilities20.3M23.7M27.3M48.0M
 
 
 
 
 
Other Liabilities32.2M30.4M34.8M65.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt88.1M209.0M206.4M200.9M
 
 
 
 
 
Other Liabilities150.0K41.1M33.1M0.00
 
 
 
 
Total Liabilities203.2M360.7M352.1M279.1M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.003.3M3.3M3.3M
 
 
 
 
Common Equity33.4M10.9M-10.0M73.4M
 
 
 
 
 
Total Shareholder Equity33.4M14.2M-6.7M76.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding14.6M14.6M14.6M14.6M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.